Recent Advances in the Discovery of Small-Molecule Inhibitors of HIV-1 Integrase
Author(s) -
Eungi Choi,
Jayapal Reddy Mallareddy,
Dai Lu,
Srikanth Kolluru
Publication year - 2018
Publication title -
future science oa
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.825
H-Index - 23
ISSN - 2056-5623
DOI - 10.4155/fsoa-2018-0060
Subject(s) - integrase , reverse transcriptase , human immunodeficiency virus (hiv) , drug discovery , viral replication , virology , biology , integrase inhibitor , computational biology , genome , drug resistance , protease , enzyme , genetics , virus , bioinformatics , gene , viral load , antiretroviral therapy , rna , biochemistry
AIDS caused by the infection of HIV is a prevalent problem today. Rapid development of drug resistance to existing drug classes has called for the discovery of new targets. Within the three major enzymes (i.e., HIV-1 protease, HIV-1 reverse transcriptase and HIV-1 integrase [IN]) of the viral replication cycle, HIV-1 IN has been of particular interest due to the absence of human cellular homolog. HIV-1 IN catalyzes the integration of viral genetic material with the host genome, a key step in the viral replication process. Several novel classes of HIV IN inhibitors have been explored by targeting different sites on the enzyme. This review strives to provide readers with updates on the recent developments of HIV-1 IN inhibitors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom